|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 260.40 DKK | +1.24% |
|
+8.21% | -19.94% |
| 18/04 | Health Care Up Ahead of Earnings - Health Care Roundup | DJ |
| 18/04 | Kailera makes a splash on Nasdaq as anti-obesity drug frenzy continues |  |
| Capitalization | 1,155B 182B 155B 142B 135B 249B 16,885B 254B 1,666B 653B 8,185B 685B 670B 28,848B | P/E ratio 2026 * |
12.3x | P/E ratio 2027 * | 12.4x |
|---|---|---|---|---|---|
| Enterprise value | 1,266B 200B 169B 156B 147B 273B 18,502B 278B 1,825B 716B 8,969B 750B 734B 31,610B | EV / Sales 2026 * |
4.43x | EV / Sales 2027 * | 4.22x |
| Free-Float |
70.25% | Yield 2026 * |
4.19% | Yield 2027 * | 4.3% |
Last Transcript: Novo Nordisk A/S
| 1 day | +1.24% | ||
| 1 week | +8.21% | ||
| Current month | +12.78% | ||
| 1 month | +4.52% | ||
| 3 months | -33.04% | ||
| 6 months | -24.00% | ||
| Current year | -19.94% |
| 1 week | 235.95 |  | 264.5 |
| 1 month | 226 | | 264.5 |
| Current year | 224.25 | | 409.95 |
| 1 year | 224.25 | | 533.4 |
| 3 years | 224.25 | | 1,033.2 |
| 5 years | 223.72 | | 1,033.2 |
| 10 years | 109.1 | | 1,033.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 07/08/2025 | |
| Director of Finance/CFO | 55 | 15/02/2018 | |
Martin Lange
CTO | Chief Tech/Sci/R&D Officer | 56 | 07/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kasim Kutay
BRD | Director/Board Member | 61 | 23/03/2017 |
| Director/Board Member | 51 | 22/03/2018 | |
| Director/Board Member | 61 | 24/03/2022 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.55% | 5.4% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.24% | +8.21% | -38.18% | -55.23% | 180B | |
| +2.55% | -1.32% | +10.37% | +148.97% | 809B | |
| -0.15% | -1.79% | +48.71% | +41.35% | 565B | |
| -0.29% | +0.21% | +20.46% | +29.28% | 370B | |
| -0.35% | 0.00% | +23.47% | +13.55% | 320B | |
| +1.72% | -0.74% | +49.33% | +27.86% | 312B | |
| +1.19% | -2.41% | +31.10% | +34.87% | 286B | |
| +3.13% | -1.94% | +52.65% | +3.53% | 285B | |
| +1.69% | +1.22% | +28.13% | +43.23% | 189B | |
| -0.66% | -0.97% | +31.66% | +64.58% | 172B | |
| Average | +1.01% | -0.69% | +25.77% | +35.20% | 348.64B | |
| Weighted average by Cap. | +1.13% | -1.24% | +27.00% | +53.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 286B 45.16B 38.25B 35.2B 33.31B 61.74B 4,179B 62.82B 412B 162B 2,026B 169B 166B 7,139B | 298B 47.14B 39.93B 36.74B 34.77B 64.44B 4,362B 65.57B 430B 169B 2,114B 177B 173B 7,452B |
| Net income | 92.25B 14.57B 12.34B 11.36B 10.75B 19.92B 1,348B 20.27B 133B 52.16B 654B 54.66B 53.52B 2,304B | 94.3B 14.89B 12.62B 11.61B 10.99B 20.36B 1,378B 20.72B 136B 53.31B 668B 55.87B 54.71B 2,355B |
| Net Debt | 111B 17.47B 14.8B 13.62B 12.89B 23.88B 1,617B 24.3B 159B 62.53B 784B 65.54B 64.17B 2,762B | 103B 16.31B 13.81B 12.71B 12.03B 22.29B 1,509B 22.68B 149B 58.36B 731B 61.16B 59.89B 2,578B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/04/26 | 260.40 kr | +1.24% | 6,440,769 |
| 16/04/26 | 257.20 kr | +2.12% | 7,032,523 |
| 15/04/26 | 251.85 kr | +2.32% | 6,242,006 |
| 14/04/26 | 246.15 kr | +3.32% | 6,509,512 |
| 13/04/26 | 238.25 kr | -1.00% | 3,605,869 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition